We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMC icon
576
Omnicom Group
OMC
$24.6B
$1.61M 0.01%
21,941
+1,603
+8% +$114K
SU icon
577
Suncor Energy
SU
$75.4B
$1.6M 0.01%
25,017
-4,182
-14% -$102K
DLTR icon
578
Dollar Tree
DLTR
$24.4B
$1.59M 0.01%
11,336
-1,242
-10% -$151K
QQQ icon
579
Invesco QQQ Trust
QQQ
$445B
$1.59M 0.01%
+4,000
New +$1.54M
SJM icon
580
J.M. Smucker
SJM
$13.2B
$1.59M 0.01%
11,690
-67,987
-85% -$8.67M
BMI icon
581
Badger Meter
BMI
$3.9B
$1.59M 0.01%
14,897
+5,233
+54% +$551K
UL icon
582
Unilever
UL
$144B
$1.58M 0.01%
26,124
ANET icon
583
Arista Networks
ANET
$214B
$1.55M 0.01%
43,240
-6,808
-14% -$203K
BF.B icon
584
Brown-Forman Class B
BF.B
$13.3B
$1.55M 0.01%
21,335
CSGP icon
585
CoStar Group
CSGP
$12.4B
$1.55M 0.01%
19,623
-1,207
-6% -$101K
AJG icon
586
Arthur J. Gallagher & Co
AJG
$68.2B
$1.52M 0.01%
8,949
XP icon
587
XP
XP
$8.68B
$1.48M 0.01%
51,615
-72,385
-58% -$2.36M
GPC icon
588
Genuine Parts
GPC
$17.9B
$1.48M 0.01%
10,537
-872
-8% -$115K
MTB icon
589
M&T Bank
MTB
$36.6B
$1.48M 0.01%
9,605
+781
+9% +$120K
ENB icon
590
Enbridge
ENB
$121B
$1.47M 0.01%
37,584
-344,598
-90% -$13.8M
RNG icon
591
RingCentral
RNG
$4.77B
$1.46M 0.01%
7,793
+2,644
+51% +$587K
SNA icon
592
Snap-on
SNA
$21.7B
$1.46M 0.01%
6,758
-28
-0.4% -$5.98K
LBRDK icon
593
Liberty Broadband Class C
LBRDK
$4.72B
$1.42M 0.01%
8,816
+1,777
+25% +$292K
OXY icon
594
Occidental Petroleum
OXY
$53.6B
$1.41M 0.01%
48,522
-6,909
-12% -$217K
LEN icon
595
Lennar Class A
LEN
$21.1B
$1.4M 0.01%
12,435
-1,486
-11% -$152K
EXPE icon
596
Expedia Group
EXPE
$35.5B
$1.37M 0.01%
7,566
-170
-2% -$28.9K
MKTX icon
597
MarketAxess Holdings
MKTX
$4.34B
$1.33M 0.01%
3,246
+1,070
+49% +$422K
EXR icon
598
Extra Space Storage
EXR
$32.2B
$1.32M 0.01%
5,827
BEN icon
599
Franklin Resources
BEN
$17.3B
$1.32M 0.01%
39,383
-3,075
-7% -$101K
PINS icon
600
Pinterest
PINS
$13.6B
$1.32M 0.01%
36,294
+3,508
+11% +$156K

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.